GeneCure is currently developing both preventative and therapeutic vaccines against a number of human diseases. These vaccines are in various stages of research and development and include a preventative vaccine against Severe Acute Respiratory Syndrome (SARS) and vaccines against Hepatitis C and Hepatitis B.

In addition, GeneCure is using its platform gene transfer technology to develop ready-to-use lentiviral particles carrying commonly used marker and reporter genes for use in basic research applications.